Previous Article | Next Article 
Journal of Virology, August 2005, p. 9786-9798, Vol. 79, No. 15
0022-538X/05/$08.00+0 doi:10.1128/JVI.79.15.9786-9798.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Mapping of the Hepatitis B Virus Pre-S1 Domain Involved in Receptor Recognition
Azeneth Barrera,1,2
Bernadette Guerra,1
Lena Notvall,1 and
Robert E. Lanford1,2*
Department of Virology and Immunology, Southwest National Primate Research Center, Southwest Foundation for Biomedical Research, San Antonio, Texas 78227,1
Department of Microbiology, The University of Texas Health Science Center at San Antonio, San Antonio, Texas 782292
Received 1 February 2005/
Accepted 18 April 2005
Hepatitis B virus (HBV) and woolly monkey hepatitis B virus (WMHBV) are primate hepadnaviruses that display restricted tissue and host tropisms. Hepatitis D virus (HDV) particles pseudotyped with HBV and WMHBV envelopes (HBV-HDV and WM-HDV) preferentially infect human and spider monkey hepatocytes, respectively, thereby confirming host range bias in vitro. The analysis of chimeric HBV and WMHBV large (L) envelope proteins suggests that the pre-S1 domain may comprise two regions that affect infectivity: one within the amino-terminal 40 amino acids of pre-S1 and one downstream of this region. In the present study, we further characterized the role of the amino terminus of pre-S1 in infectivity by examining the ability of synthetic peptides to competitively block HDV infection of primary human and spider monkey hepatocytes. A synthetic peptide representing the first 45 residues of the pre-S1 domain of the HBV L protein blocked infectivity of HBV-HDV and WM-HDV, with a requirement for myristylation of the amino terminal residue. Competition studies with truncated peptides suggested that pre-S1 residues 5 to 20 represent the minimal domain for inhibition of HDV infection and, thus, presumably represent the residues involved in virus-host receptor interaction. Recombinant pre-S1 proteins expressed in insect cells blocked infection with HBV-HDV and WM-HDV at a concentration of 1 nanomolar. The ability of short pre-S1 peptides to efficiently inhibit HDV infection suggests that they represent suitable ligands for identification of the HBV receptor and that a pre-S1 mimetic may represent a rational therapy for the treatment of HBV infection.
* Corresponding author. Mailing address: Department of Virology and Immunology, Southwest National Primate Research Center, Southwest Foundation for Biomedical Research, 7620 NW Loop 410, San Antonio, TX 78227. Phone: (210) 258-9445. Fax: (210) 670-3329. E-mail:
rlanford{at}sfbr.org.
Journal of Virology, August 2005, p. 9786-9798, Vol. 79, No. 15
0022-538X/05/$08.00+0 doi:10.1128/JVI.79.15.9786-9798.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Le Duff, Y., Blanchet, M., Sureau, C.
(2009). The Pre-S1 and Antigenic Loop Infectivity Determinants of the Hepatitis B Virus Envelope Proteins Are Functionally Independent. J. Virol.
83: 12443-12451
[Abstract]
[Full Text]
-
Thaa, B., Kabatek, A., Zevenhoven-Dobbe, J. C., Snijder, E. J., Herrmann, A., Veit, M.
(2009). Myristoylation of the arterivirus E protein: the fatty acid modification is not essential for membrane association but contributes significantly to virus infectivity. J. Gen. Virol.
90: 2704-2712
[Abstract]
[Full Text]
-
Abou-Jaoude, G., Sureau, C.
(2007). Entry of Hepatitis Delta Virus Requires the Conserved Cysteine Residues of the Hepatitis B Virus Envelope Protein Antigenic Loop and Is Blocked by Inhibitors of Thiol-Disulfide Exchange. J. Virol.
81: 13057-13066
[Abstract]
[Full Text]
-
Chai, N., Chang, H. E., Nicolas, E., Gudima, S., Chang, J., Taylor, J.
(2007). Assembly of Hepatitis B Virus Envelope Proteins onto a Lentivirus Pseudotype That Infects Primary Human Hepatocytes. J. Virol.
81: 10897-10904
[Abstract]
[Full Text]
-
Blanchet, M., Sureau, C.
(2007). Infectivity Determinants of the Hepatitis B Virus Pre-S Domain Are Confined to the N-Terminal 75 Amino Acid Residues. J. Virol.
81: 5841-5849
[Abstract]
[Full Text]
-
Chai, N., Gudima, S., Chang, J., Taylor, J.
(2007). Immunoadhesins Containing Pre-S Domains of Hepatitis B Virus Large Envelope Protein Are Secreted and Inhibit Virus Infection. J. Virol.
81: 4912-4918
[Abstract]
[Full Text]
-
Gudima, S., Meier, A., Dunbrack, R., Taylor, J., Bruss, V.
(2007). Two Potentially Important Elements of the Hepatitis B Virus Large Envelope Protein Are Dispensable for the Infectivity of Hepatitis Delta Virus. J. Virol.
81: 4343-4347
[Abstract]
[Full Text]
-
Gudima, S., He, Y., Meier, A., Chang, J., Chen, R., Jarnik, M., Nicolas, E., Bruss, V., Taylor, J.
(2007). Assembly of Hepatitis Delta Virus: Particle Characterization, Including the Ability To Infect Primary Human Hepatocytes. J. Virol.
81: 3608-3617
[Abstract]
[Full Text]
-
Blanchet, M., Sureau, C.
(2006). Analysis of the Cytosolic Domains of the Hepatitis B Virus Envelope Proteins for Their Function in Viral Particle Assembly and Infectivity. J. Virol.
80: 11935-11945
[Abstract]
[Full Text]